Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Team Grant: ERDERA Joint Transnational Call

McGill University

$385,500.00

Towards synergistic treatments for Leigh Syndrome Spectrum disorders

FY 2025-26

Summary
Leigh syndrome spectrum (LSS) disorders affect 1:40,000 live births, causing neurodevelopmental delay, movement impairment, and early death. Most LSS forms are currently incurable. The Consortium SynLeigh aims to identify therapeutic interventions and their potential synergy to develop a roadmap for developing clinical trials for LSS. Members of our consortium previously discovered two potential therapeutics for which they have already obtained orphan drug designation (ODD) for their use in LSS. We will leverage these findings to assess the effectiveness and toxicity of these molecules and their possible synergy. We will employ complementary approaches using patient-derived human models (including neurons, brain organoids, blood-brain barrier, and Organs-on-chip technologies), followed by validations and toxicology assessment in small and large animal models, and computational integrations. We have already initiated to engage with the European Medicine Agency (EMA) and their indications will guide our experimental design to collect findings that are deemed satisfactory by the regulators. Altogether, we aim to provide a mechanistic understanding and practical strategy for the establishment of treatments for individuals affected by currently incurable LSS disorders.
Program
Team Grant: ERDERA Joint Transnational Call
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
532026
Name
Cuella Martin Raquel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
German Federal Ministry of Research, Technology and Space (Berlin); National Research Fund (Luxembourg); Fondazione Regionale per la Ricerca Biomedica (Milan, Italy); Instituto de Salud Carloss III (Spain); Ministry of Education and Science (Latvia); The Netherlands Organization for Health Research and Development (ZonMw)
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Team Grant: ERDERA Joint Transnational Call
Projecttitle
Towards synergistic treatments for Leigh Syndrome Spectrum disorders
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$385,500
Cihrequipment2
$0
Programname2
Team Grant: ERDERA Joint Transnational Call
Keyworddelim
Cbd; Combination Therapies; Crispr-Based Screens; Drug Repurposing; Leigh Syndrome; Preclinical Analyses; Sildenafil
Abstract
Leigh syndrome spectrum (LSS) disorders affect 1:40,000 live births, causing neurodevelopmental delay, movement impairment, and early death. Most LSS forms are currently incurable. The Consortium SynLeigh aims to identify therapeutic interventions and their potential synergy to develop a roadmap for developing clinical trials for LSS. Members of our consortium previously discovered two potential therapeutics for which they have already obtained orphan drug designation (ODD) for their use in LSS. We will leverage these findings to assess the effectiveness and toxicity of these molecules and their possible synergy. We will employ complementary approaches using patient-derived human models (including neurons, brain organoids, blood-brain barrier, and Organs-on-chip technologies), followed by validations and toxicology assessment in small and large animal models, and computational integrations. We have already initiated to engage with the European Medicine Agency (EMA) and their indications will guide our experimental design to collect findings that are deemed satisfactory by the regulators. Altogether, we aim to provide a mechanistic understanding and practical strategy for the establishment of treatments for individuals affected by currently incurable LSS disorders.
Competitiondate
202507
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cuella Martin, Raquel
Approvedterm
3 ans 0 mois
Cihrcontribution2
IG~ $385,500~ $0~
McGill University - $385,500 Grant (2025-26) | Canada Spends